Skip Navigation
Dispensary Info
Closed
Available for pre-order
Dispensary Info
Closed
Available for pre-order
Image of product

Regular Strength Cannabis Tincture, 1000mg, 2oz

7 left in stock – order soon!

$75.98
1

*Cannabis and Sales tax not included.

THC is the primary cannabinoid responsible for the psychoactive effects associated with cannabis. The amount of THC in a product can vary widely based on the method of consumption and the strain at the source of that product. The high that is produced is often enhanced by the “entourage effect” which is a combination of multiple cannabinoids in conjunction with various terpenes and individual body chemistry.

CBD is the second most prevalent cannabinoid and is primarily produced by hemp plants and at lower amounts in cannabis. CBD has soared in popularity due to its non-psychoactive effects.

Our award‑winning 20:1 CBD:THC formulation has been trusted since 2015. This formula is now referred to as Regular Strength. Recommended uses include: • Supporting joint mobility • Supporting normal brain function • Helping maintain normal GI health • Helping maintain calmness Available in 1 oz and 2 oz sizes. Product features: • Easy‑to‑measure tincture • Doctor‑formulated • Complimentary support from medical professionals • Premium, carefully selected ingredients Every batch is tested by state‑certified laboratories in accordance with California cannabis testing regulations to ensure quality and safety.

Effects
Calm
About the Brand
VetCBD Logo

VETCBD's team of veterinary professionals are on a mission to improve the lives of the animals we share our world with.

Dr. Tim Shu is the founder and chief executive officer of VETCBD. Dr. Shu founded VETCBD so pets could safely benefit from the multiple therapeutic uses of cannabis. By combining his expertise in veterinary medicine with his knowledge of medical cannabis, Dr. Shu formulates VETCBD products to be safe and effective for use in animals.

Dr. Shu’s work on cannabis and pets has garnered international attention and has been featured by The Today Show, CNBC, NPR, and The New York Times.